Elranatamab (ELREXFIO) - a BCMA x CD3 Bispecific Antibody for Multiple Myeloma
Discover the science behind Elrexfio (elranatamab) — a groundbreaking bispecific antibody treatment offering new hope for patients with relapsed or refractory multiple myeloma. In this video, we break down how Elrexfio works, its FDA-approved uses, clinical trial results, side effects, and what makes it a promising advancement in precision oncology. 🔬 What You’ll Learn: What is Elrexfio (elranatamab)? How it targets BCMA and CD3 to fight multiple myeloma Who it's for: indications and patient eligibility Results from the MagnetisMM trials Common side effects and safety profile How this fits into the future of personalized medicine 📅 Approved by the FDA in 2023, Elrexfio represents a major step forward in immunotherapy and targeted treatment options for myeloma patients who've exhausted other therapies. 🔔 Don't forget to like, subscribe, and click the bell icon for more videos on the latest in cancer research and precision medicine! #Elrexfio #Elranatamab #MultipleMyeloma #CancerTreatment #PrecisionMedicine #BCMATherapy #Immunotherapy #MyelomaAwareness Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer! Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_so... Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.
Linvoseltamab (LYNOZYFIC ) - a BCMA x CD3 Bispecific Antibody for Multiple Myeloma
ELREXFIO (elranatamab) for Multiple Myeloma: Patient Story + Doctor Explains
Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t
Talquetamab (TALVEY) -a GPRC5D x CD3 Bispecific Antibody for Multiple Myeloma
How AI Cracked the Protein Folding Code and Won a Nobel Prize
What are the barriers to research in the community oncology setting?
Introduction to Suture
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
Relapsed Multiple Myeloma: What Every Patient Needs to Know
The Modern Myeloma Toolbox | Tarek Mouhieddine, MD #myeloma
Elranatamab: How it works, how it's being used, and how it compares to other bispecifics.
Britain Sold Palestine to Pay Its WWI Debt. The Balfour Declaration Was a Banking Deal!
Learn Your Labs | High Impact Topic (HIT)
These Two Drugs Eliminated Cancer Metastasis | Here's What You Need to Know
Innovations in Myeloma Therapies: Promise of ADCs, CELMoDs, BCL2 Inhibitors, & SINEs | Dan Vogl, MD
TECVAYLI (Teclistamab) Everything You Need to Know- newer version available see link 👇
Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting
This New Histamine Treatment Helped 89% of Patients
What is the clinical experience with elranatamab for the treatment of multiple myeloma?
